These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33634433)

  • 1. Latest advances to enhance the therapeutic potential of mesenchymal stromal cells for the treatment of immune-mediated diseases.
    Ceruso A; Gonzalez-Pujana A; Igartua M; Santos-Vizcaino E; Hernandez RM
    Drug Deliv Transl Res; 2021 Apr; 11(2):498-514. PubMed ID: 33634433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
    Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
    Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
    Zimmermann JA; McDevitt TC
    Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the Properties of Biomaterial to Enhance the Immunomodulation of Mesenchymal Stem Cells.
    Chen Y; Shu Z; Qian K; Wang J; Zhu H
    Tissue Eng Part B Rev; 2019 Dec; 25(6):492-499. PubMed ID: 31436142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
    Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
    Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cell based therapies for the treatment of immune disorders: recent milestones and future challenges.
    Gonzalez-Pujana A; Igartua M; Santos-Vizcaino E; Hernandez RM
    Expert Opin Drug Deliv; 2020 Feb; 17(2):189-200. PubMed ID: 31918562
    [No Abstract]   [Full Text] [Related]  

  • 7. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
    Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
    PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs.
    Weiss ARR; Dahlke MH
    Front Immunol; 2019; 10():1191. PubMed ID: 31214172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential.
    Song N; Scholtemeijer M; Shah K
    Trends Pharmacol Sci; 2020 Sep; 41(9):653-664. PubMed ID: 32709406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion.
    Srinivasan A; Sathiyanathan P; Yin L; Liu TM; Lam A; Ravikumar M; Smith RAA; Loh HP; Zhang Y; Ling L; Ng SK; Yang YS; Lezhava A; Hui J; Oh S; Cool SM
    Cytotherapy; 2022 May; 24(5):456-472. PubMed ID: 35227601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled aggregation enhances immunomodulatory potential of mesenchymal stromal cell aggregates.
    Xie AW; Zacharias NA; Binder BYK; Murphy WL
    Stem Cells Transl Med; 2021 Aug; 10(8):1184-1201. PubMed ID: 33818906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
    Zimmermann JA; Hettiaratchi MH; McDevitt TC
    Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism.
    Li H; Dai H; Li J
    J Adv Res; 2023 Mar; 45():15-29. PubMed ID: 35659923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases.
    Shi Y; Wang Y; Li Q; Liu K; Hou J; Shao C; Wang Y
    Nat Rev Nephrol; 2018 Aug; 14(8):493-507. PubMed ID: 29895977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application.
    Lee BC; Kang KS
    Stem Cell Res Ther; 2020 Sep; 11(1):397. PubMed ID: 32928306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating MSC Therapy in the Age of Obesity.
    Boland L; Bitterlich LM; Hogan AE; Ankrum JA; English K
    Front Immunol; 2022; 13():943333. PubMed ID: 35860241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional biomimetic hydrogel systems to boost the immunomodulatory potential of mesenchymal stromal cells.
    Gonzalez-Pujana A; Vining KH; Zhang DKY; Santos-Vizcaino E; Igartua M; Hernandez RM; Mooney DJ
    Biomaterials; 2020 Oct; 257():120266. PubMed ID: 32763614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.